- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2015
- Public Summary Document (PSD) March 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2015 PBAC Meeting - Word
Canakinumab – March 2015
Canakinumab; 150 mg injection: powder for, 1 vial, 150 mg injection: powder for, 4 vials; Ilaris®
Last updated
3 July 2015